2型糖尿病遗传风险修饰以预防妊娠期和产后糖尿病为目标的生活方式干预的效果
RADIEL随机对照试验评估50个2型糖尿病风险变异构成的多基因风险评分(PRS)与生活方式干预的交互作用。516名参与者提供遗传与妊娠期糖尿病(GDM)数据;在孕期首次访视无GDM的386人中,PRS与干预存在交互作用(孕期p=0.016,产后p=0.024),干预仅在遗传风险最高三分位组降低年龄调整的GDM发生(OR 0.37;95%CI 0.17,0.82)。
要点
- PRS与生活方式干预对GDM及产后血糖异常存在交互作用(孕期p=0.016,产后p=0.024)。
- 遗传风险最高三分位组中,干预降低年龄调整的GDM发生(OR 0.37;95%CI 0.17,0.82)。
- 该组产后12个月血糖异常风险亦降低(OR 0.35;95%CI 0.13,0.97)。
核心结论
- 糖尿病的遗传易感性修饰了以预防GDM和产后糖尿病为目标的生活方式干预的反应,提示生活方式干预或可根据遗传风险进行个体化调整。
研究设计与样本
- RADIEL研究为通过生活方式干预预防GDM和产后糖尿病的随机对照试验(RCT)。
- BMI≥30 kg/m2和/或既往GDM的参与者在孕前或孕早期被分配至干预组和对照组。
- 研究访视在孕前每3个月、每个孕期一次、产后6周及6和12个月进行。
- 基于50个2型糖尿病风险变异计算多基因风险评分(PRS)。
主要发现
- 共516名参与者提供遗传和GDM数据。
- PRS与第二、第三孕期及产后12个月较高的血糖水平(空腹血糖和/或HbA1c)及较低的胰岛素分泌指数相关。
- PRS与较高的GDM发生及产后12个月血糖异常发生相关(n=356)。
- 在孕期首次研究访视无GDM的参与者(n=386)中,PRS与生活方式干预存在交互作用(孕期p=0.016,产后p=0.024)。
- 按PRS三分位分析,干预仅在遗传风险最高组降低年龄调整的GDM发生(OR 0.37;95%CI 0.17,0.82)。
临床怎么用
- 原文结论认为,生活方式干预或可根据遗传风险进行个体化调整。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to assess the interaction between genetic risk and lifestyle intervention on the occurrence of gestational diabetes mellitus (GDM) and postpartum diabetes. METHODS: The RADIEL study is an RCT aimed at prevention of GDM and postpartum diabetes through lifestyle intervention. Participants with a BMI ≥30 kg/m2 and/or prior GDM were allocated to intervention and control groups before pregnancy or in early pregnancy. The study visits took place every 3 months before pregnancy, once in each trimester, and at 6 weeks and 6 and 12 months postpartum. We calculated a polygenic risk score (PRS) based on 50 risk variants for type 2 diabetes. RESULTS: Altogether, 516 participants provided genetic and GDM data. The PRS was associated with higher glycaemic levels (fasting glucose and/or HbA1c) and a lower insulin secretion index in the second and third trimesters and at 12 months postpartum, as well as with a higher occurrence of GDM and glycaemic abnormalities at 12 months postpartum (n = 356). There was an interaction between the PRS and lifestyle intervention (p=0.016 during pregnancy and p=0.024 postpartum) when analysing participants who did not have GDM at the first study visit during pregnancy (n = 386). When analysing women in tertiles according to the PRS, the intervention was effective in reducing the age-adjusted occurrence of GDM only among those with the highest genetic risk (OR 0.37; 95% CI 0.17, 0.82). The risk of glycaemic abnormalities at 12 months postpartum was reduced in the same group after adjusting additionally for BMI, parity, smoking and education (OR 0.35; 95% CI 0.13, 0.97). CONCLUSIONS/INTERPRETATION: Genetic predisposition to diabetes modifies the response to a lifestyle intervention aimed at prevention of GDM and postpartum diabetes. This suggests that lifestyle intervention may benefit from being tailored according to genetic risk. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01698385.
引用
- Huvinen E, Lahti J, Klemetti MM, et al. Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetes. Diabetologia. 2022. PMID: 35501401. doi:10.1007/s00125-022-05712-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。